UNSPSC 51131636: Efegatran

This classification denotes a protease inhibitor and anticoagulant agent with the molecular formula C21H32N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, VT0VK2474K chemically known as l-prolinamide, n-methyl-d-phenylalanyl-n-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (s)- but generally known as efegatran, which bears US NIH Compound Identifier 122267. European Medicines Agency schedules Efegatran in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06464MIG.

UNSPSC 51131636 Efegatran, a Commodity code, does not appear in current state and local procurement activity based on available recent opportunities. Sourcewell, a Minnesota cooperative purchasing vehicle, posted RFP #061626 on May 12, 2026, for Law Enforcement Equipment under this code identifier, with a June 16, 2026 response deadline, but the actual solicitation scope—law enforcement equipment procurement for thousands of governmental agencies across multiple jurisdictions—does not align with the specific pharmaceutical or medical product implied by the code name. The mismatch between code assignment and stated work scope suggests either a tagging error or a code reassignment that does not reflect typical state and local purchasing patterns for this commodity.

The single identified opportunity spans Sourcewell's cooperative purchasing network across multiple states including Washington, Minnesota, and numerous other jurisdictions nationwide, with stated participation from Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties in Washington. Vendors must submit proposals through the Sourcewell Procurement Portal by 3:30 p.m. Central Time on June 16, 2026. Until additional state and local opportunities surface under this code that clarify whether it is being applied to a consistent product category or whether the tagging reflects actual purchasing intent, the code shows minimal relevant activity in the current market.